The Irish-American “Green & Health” joins in with its Italian pharmaceutical partner to develop an Anti-Malaria strategy to help eradicate the disease from in Africa.
GreenWorld, a progressing entity in the global market for the environmental health and energy products, is in the process of forming a joint venture, the goal of which is to provide the Sub-Saharan people with the environmentally friendly and affordable housing solutions.
In collaboration with its Italian pharmaceutical associate, GreenWorld has developed a new and a unique technology that ferments and impregnates the building panels and blocks with repellents that are anti-mosquito in nature.
According to the statistics, Malaria causes the death of 34,000 children of age five or younger in Kenya, that’s around 100 a day, quite alarming. The building contractors and the health and Government organizations are expected to have the repellent for its further use.
The toxic chemical used in the formula of the repellent is not harmful to the humans and needs to be replenished after two years. This fact also guarantees a continuous income for GreenWorld from the primary supplies it sells as well as the replenishment of the chemical every two years.
GreenWorld is listed on the US OTC Bulletin Board (OTC:FRXP). Developing competitive, innovative and sustainable products is what GreenWorld is committed to. With its main focus on carbon-emission technologies & trading, R&D, healthcare & pharmaceutical, GreenWorld strives to build sustainable, competitive, innovative, competitive environmentally friendly technologies along with consultancy in the emerging market.
The new strategies to combat Malaria may be a source of great hope for the people of the region thus saving a great number of precious lives. Steps like these can greatly enhance the chances of a better living for all us humans.